Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach.
about
Amniotic Fluid Stem Cells: A Novel Source for Modeling of Human Genetic DiseasesThe Regenerative Role of the Fetal and Adult Stem Cell SecretomeThe decision on the "optimal" human pluripotent stem cellThe quest for an effective and safe personalized cell therapy using epigenetic toolsEngineering muscle tissue for the fetus: getting ready for a strong lifeOsteogenic differentiation of amniotic fluid mesenchymal stromal cells and their bone regeneration potentialDifferentiation of spontaneously contracting cardiomyocytes from non-virally reprogrammed human amniotic fluid stem cells.Genome-wide analysis reveals the unique stem cell identity of human amniocytesGenetic reprogramming of human amniotic cells with episomal vectors: neural rosettes as sentinels in candidate selection for validation assaysIn utero therapy for congenital disorders using amniotic fluid stem cells.Immune regulatory properties of CD117(pos) amniotic fluid stem cells vary according to gestational ageAmniotic fluid stem cells inhibit the progression of bleomycin-induced pulmonary fibrosis via CCL2 modulation in bronchoalveolar lavageMicroRNA-26a induced by hypoxia targets HDAC6 in myogenic differentiation of embryonic stem cells.Molecular and cellular characteristics of human and non-human primate multipotent stromal cells from the amnion and bone marrow during long term cultureExcessive Cellular Proliferation Negatively Impacts Reprogramming Efficiency of Human FibroblastsEndothelial properties of third-trimester amniotic fluid stem cells cultured in hypoxiaPushing the reset button: chemical-induced conversion of amniotic fluid stem cells into a pluripotent stateAdipogenic placenta-derived mesenchymal stem cells are not lineage restricted by withdrawing extrinsic factors: developing a novel visual angle in stem cell biology.Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions.AF-MSCs fate can be regulated by culture conditionsWnt signaling behaves as a "master regulator" in the osteogenic and adipogenic commitment of human amniotic fluid mesenchymal stem cells.Induced pluripotent stem (iPS) cells from human fetal stem cells (hFSCs).First steps to define murine amniotic fluid stem cell microenvironment.Migration, proliferation, and differentiation of cord blood mesenchymal stromal cells treated with histone deacetylase inhibitor valproic Acid.Chondrogenic differentiation of amniotic fluid stem cells and their potential for regenerative therapy.CD117(+) amniotic fluid stem cells: state of the art and future perspectives.Technological overview of iPS induction from human adult somatic cells.Intercellular protein expression variability as a feature of stem cell pluripotency.Stem cells as a potential therapy for necrotizing enterocolitis.Stem cells from fetal membranes and amniotic fluid: markers for cell isolation and therapy.Amniotic fluid-derived mesenchymal stem cells: characteristics and therapeutic applications.Advancing stem cell therapy from bench to bedside: lessons from drug therapiesEpigenetic modulation of dental pulp stem cells: implications for regenerative endodontics.Heart valve tissue engineering: how far is the bedside from the bench?Erase and Rewind: Epigenetic Conversion of Cell Fate.TGFβ-induced osteogenic potential of human amniotic fluid stem cells via CD73-generated adenosine productionValproic Acid Enhances iPSC Induction From Human Bone Marrow-Derived Cells Through the Suppression of Reprogramming-Induced Senescence.Human Cardiomyocytes Prior to Birth by Integration-Free Reprogramming of Amniotic Fluid Cells.Human Amniocytes Are Receptive to Chemically Induced Reprogramming to Pluripotency.Concise Review: Amniotic Fluid Stem Cells: The Known, the Unknown, and Potential Regenerative Medicine Applications.
P2860
Q26750573-8E911B85-AC91-455E-9542-089C02181836Q27004398-09B112B0-3104-4B46-BA64-B4777DBD847EQ27008812-78103416-558E-431E-A3CC-971881733CE2Q28079389-7B547FD1-5541-4747-B6DF-E4214DC50F97Q28084505-31B93D19-08EB-400E-8422-81AC0F72AB00Q28085458-E74D4686-A886-47D1-A860-D39977C2715AQ33699342-3B006314-8184-436A-8E7F-3EC60852F57BQ34551352-89ABED2F-8779-4CBB-B50D-4CFDE00517DEQ34568711-3939BED7-9001-494E-9EB8-B499867438D0Q34741419-611949B1-410F-459D-B2AF-ED9B00E14090Q34751229-5F53B067-886B-4886-A9DC-B2CCCAB4FC3BQ34964361-5EF5C645-FE99-4DD8-9965-FF417A833414Q35131168-F3F8A336-C458-4AB6-A0FB-24CC45882ACFQ35986912-ED5374D9-3824-48E5-89B7-ABE4A051F6FDQ36067828-A6CA21C0-D7C4-400E-96C2-1DB171492C02Q36234999-F245F80D-C5C7-4168-8A90-894504BF9474Q36298670-ED1A4375-BF63-4649-8A14-B86A79CAE2ABQ36774930-46EE2FC0-A495-431A-9213-41AF318A0938Q36781413-5A6154C9-334A-435B-9629-5FD33D9CFAADQ36890227-7F3F6ED4-23DD-43DD-BA81-3926211695FAQ37202311-91A9DEDA-ED96-4A6B-91E6-1F28C3584DAFQ37265783-190DC165-EAE0-4553-9192-6F063FF098DEQ37413888-919A7D8F-3D2F-43E0-B644-F824367EB7F0Q37686598-C15A492E-F9D3-4ECB-9D75-38FF05E6AC01Q38032509-EF0160B2-5FF2-4C5D-B85B-945354D5135CQ38049499-722867E7-3B18-4E2F-9D98-FD30281AA302Q38074176-CDA53837-4F01-41B1-9B2E-681FE8025433Q38146781-2E03835B-8985-499D-9D26-68AEF0D7B253Q38154935-80EE8902-605E-4F40-955D-90E224202366Q38189737-F2A1256A-9227-4085-8A56-74199005931CQ38205387-CA7B9F4C-4035-4163-9F6B-639F1FDF3022Q38245564-3F657298-FA89-40FD-8109-E00E7F8FC729Q38502939-D51D87FA-0C8E-4DC5-B77C-F703F6E1D141Q38591747-86BA7067-0F94-4D47-818E-3BE9615DA255Q38640670-DCCCF3B6-6AA3-4C53-9DD6-8674610AE51FQ38659134-06200C2B-6601-43C2-B986-FFD78BEC2FB8Q38815636-F122C9DF-9C3E-4938-AE66-F19CFA28E126Q38910418-6C1C5867-B6F2-4803-A2D1-33F9C38405E6Q38983619-6A43376B-1795-4D17-9537-0877D4EC2E72Q39051358-54BED966-4CDF-4F2C-92FE-6E2C521BCA48
P2860
Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Valproic acid confers function ...... in a transgene-free approach.
@ast
Valproic acid confers function ...... in a transgene-free approach.
@en
type
label
Valproic acid confers function ...... in a transgene-free approach.
@ast
Valproic acid confers function ...... in a transgene-free approach.
@en
prefLabel
Valproic acid confers function ...... in a transgene-free approach.
@ast
Valproic acid confers function ...... in a transgene-free approach.
@en
P2093
P2860
P50
P356
P1433
P1476
Valproic acid confers function ...... in a transgene-free approach.
@en
P2093
Anju Phoolchund
Beata Nowakowska
Dafni Moschidou
Daniel Nettersheim
Gemma N Jones
Gudrun Moore
Hassan Abdulrazzak
Jennifer Frost
Joris R Vermeesch
Katharina Drews
P2860
P304
P356
10.1038/MT.2012.117
P50
P577
2012-07-03T00:00:00Z